Medical Faculty, Institute for Experimental Epileptology and Cognition Research, University of Bonn, Bonn, Germany.
BIAL -Portela & Ca. SA, S. Mamede do Coronado, Portugal.
Epilepsia. 2021 Feb;62(2):542-556. doi: 10.1111/epi.16808. Epub 2021 Jan 16.
Many antiseizure drugs (ASDs) act on voltage-dependent sodium channels, and the molecular basis of these effects is well established. In contrast, how ASDs act on the level of neuronal networks is much less understood.
In the present study, we determined the effects of eslicarbazepine (S-Lic) on different types of inhibitory neurons, as well as inhibitory motifs. Experiments were performed in hippocampal slices from both sham-control and chronically epileptic pilocarpine-treated rats.
We found that S-Lic causes an unexpected reduction of feed-forward inhibition in the CA1 region at high concentrations (300 µM), but not at lower concentrations (100 µM). Concurrently, 300 but not 100 μM S-Lic significantly reduced maximal firing rates in putative feed-forward interneurons located in the CA1 stratum radiatum of sham-control and epileptic animals. In contrast, feedback inhibition was not inhibited by S-Lic. Instead, application of S-Lic, in contrast to previous data for other drugs like carbamazepine (CBZ), resulted in a lasting potentiation of feedback inhibitory post-synaptic currents (IPSCs) only in epileptic and not in sham-control animals, which persisted after washout of S-Lic. We hypothesized that this plasticity of inhibition might rely on anti-Hebbian potentiation of excitatory feedback inputs onto oriens-lacunosum moleculare (OLM) interneurons, which is dependent on Ca -permeable α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors. Indeed, we show that blocking Ca -permeable AMPA receptors completely prevents upmodulation of feedback inhibition.
These results suggest that S-Lic affects inhibitory circuits in the CA1 hippocampal region in unexpected ways. In addition, ASD actions may not be sufficiently explained by acute effects on their target channels, rather, it may be necessary to take plasticity of inhibitory circuits into account.
许多抗癫痫药物(ASDs)作用于电压门控钠离子通道,这些作用的分子基础已得到很好的确立。相比之下,ASDs 如何作用于神经元网络的水平则知之甚少。
在本研究中,我们确定了依佐加滨(S-Lic)对不同类型抑制性神经元以及抑制性基序的作用。实验在来自假手术对照和慢性匹鲁卡品处理的大鼠的海马切片中进行。
我们发现 S-Lic 在高浓度(300µM)下会导致 CA1 区的前馈抑制异常减少,但在低浓度(100µM)下则不会。同时,300µM 而非 100µM 的 S-Lic 显著降低了位于假手术对照和癫痫动物 CA1 放射层的推定前馈中间神经元的最大放电率。相比之下,S-Lic 并未抑制反馈抑制。相反,与先前关于卡马西平(CBZ)等其他药物的研究数据相反,S-Lic 的应用仅在癫痫动物中而不在假手术对照动物中导致反馈抑制性突触后电流(IPSCs)的持久增强,并且在 S-Lic 冲洗后仍然存在。我们假设这种抑制的可塑性可能依赖于兴奋性反馈输入对或门-腔隙分子(OLM)中间神经元的反赫布式增强,这依赖于钙通透性 α-氨基-3-羟基-5-甲基-4-异恶唑丙酸(AMPA)受体。事实上,我们表明阻断钙通透性 AMPA 受体可完全防止反馈抑制的上调。
这些结果表明,S-Lic 以意想不到的方式影响 CA1 海马区的抑制性电路。此外,ASD 的作用不能仅通过其靶通道的急性作用来充分解释,而可能需要考虑抑制性电路的可塑性。